What’s New in Radiation Oncology? [Webchat]

0

At Dana-Farber, radiation oncologists like Dr. David Kozono, MD, PHD work to improve outcomes in cancer through research and deliver quality care to patients through radiation therapy.

About two-thirds of cancer patients undergo radiation therapy as part of their treatment. What new developments are occurring in the world of radiation?

According to Kozono, technological advances to modern computers haved allowed radiation oncologists to treat cancer with more strength and precision. Techniques like Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT) shape and guide X-rays to direct higher doses of radiation that destroy tumors and kill cancer faster.

Kozono is also particularly excited by advances in immunotherapy and how it can work in partnership with radiation therapy to help treat cancer.

During a recent Facebook Live webchat, Kozono answered questions from the audience and discussed what patients should ask their radiation oncologist before treatment.

Kozono explained that when patients talk with their radiation oncologist, they should consider their diagnosis, what kind of radiation therapy they’re receiving, how many treatments they will undergo, and what side effects they might expect.

“The most important questions, really, are the ones that patients and loved ones want to ask,” he says.

View a video of the Feb. 16 webchat below.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Dana-Farber #researchers have shown that clonal hematopoiesis of indeterminate potential (CHIP) - the presence of s… https://t.co/ZlmXSeyKfZ
Dana-Farber @danafarber
CRISPR, a powerful new tool for editing the #DNA instruction manual in animals and humans, is proving a boon to… https://t.co/pCzS3riHPS

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.